JULÄINE: The Injectable That Teaches Your Skin to Rebuild Itself

If you've spent any time in aesthetics recently, you'll have noticed a shift. We're moving away from adding volume with fillers and towards something far more interesting: teaching your own skin to rebuild itself.

JULÄINE is at the sharp end of that shift, and it's one of the treatments I get asked about most in clinic.

What Actually Is JULÄINE?

JULÄINE is a next generation PLLA (poly-L-lactic acid) collagen biostimulator, developed by Nordberg Medical in Sweden. It's injected into the skin, where it works not by filling space, but by sending a physical signal to your fibroblasts, the cells responsible for producing collagen.

Think of it less like adding scaffolding and more like instructing your body's own building crew to get back to work.

The result is a gradual, progressive improvement in skin density, firmness and texture, driven by your own biology, not a foreign substance sitting in the tissue.

What Does PLLA Actually Do?

Poly-L-lactic acid has been used in medicine for decades. It's the same biodegradable material used in dissolvable sutures. In aesthetics, it was popularised by Sculptra, which has been around since the early 2000s.

JULÄINE is a genuine evolution of that technology, built around Nordberg Medical's proprietary LASYNPRO technology (Lactic Acid Induced Synthesis of Collagen Protein). In plain terms, this is a manufacturing process that produces PLLA microspheres of a highly uniform, smooth, spherical shape, rather than the more irregular particles found in older PLLA products.

Why does the shape matter so much? Because it's the shape and uniformity of these particles that determines how your body responds to them. LASYNPRO's refined formulation is designed to:

• Stimulate collagen production more efficiently

• Reduce the risk of the nodule formation that was occasionally associated with earlier, less uniform PLLA particles

• Support a more even, gradual, and genuinely regenerative tissue response, rather than one built on a rough inflammatory reaction

It breaks down slowly over time, and as it does, it leaves behind new collagen matrix. The treatment itself disappears. The improvement stays.

The Part That Actually Excites Me: The Immune Pathway

Most people assume that with an injectable treatment, the less immune activity the better. With JULÄINE, the immune response is the treatment. It's just recruited in the right way, and channelled down the right pathway.

When PLLA microspheres are placed into the tissue, your immune system responds. Macrophages, your body's first responders, arrive to assess the situation. What happens next is where JULÄINE, and its LASYNPRO engineering, distinguishes itself.

There are two broad states a macrophage can settle into, and they matter enormously here.

M1 macrophages are pro-inflammatory. They release cytokines like TNF-alpha, IL-1beta and IL-6, the same mediators I talk about constantly in the context of inflammageing and chronic disease. M1 macrophages are also metabolically "quick and dirty": they run on glycolysis, burning glucose fast for an immediate burst of inflammatory activity. That's useful after an injury. It's not what you want driving a long-term skin treatment. M1 dominance leads to tissue breakdown, not repair.

M2 macrophages are the opposite: anti-inflammatory and genuinely pro-regenerative. They release IL-10 and TGF-beta, they calm destructive inflammation, and critically, they switch fibroblasts on to start producing collagen. Metabolically, M2 macrophages run a different engine entirely: they favour mitochondrial oxidative phosphorylation over glycolysis, which is a slower, cleaner, more sustainable way of generating energy. This is what a metabolically healthy cell looks like, and it's the state your skin's repair crew needs to be in for real regeneration to happen.

JULÄINE's LASYNPRO formulation is specifically engineered to drive an M2-dominant response. Your immune system is recruited, but channelled towards repair rather than inflammation, and towards a metabolically healthier cellular environment rather than an inflammatory one.

Why does this matter so much? Because chronic, low grade inflammation, the M1-driven kind, is one of the primary mechanisms behind collagen degradation as we age. It's not just that we produce less collagen in our forties and fifties, it's that inflammation actively breaks down what we already have, faster than we can replace it. Treating the skin with something that compounds that problem would be entirely counterproductive.

JULÄINE does the opposite. It uses a precisely engineered biological signal to activate the body's own healing and regenerative machinery, and to nudge your skin's cellular metabolism towards a healthier state, without triggering the inflammatory cascade that accelerates ageing in the first place.

For someone who cares about their inflammation markers as much as their reflection, that distinction is not small. It's the whole point.

Why Does This Matter Clinically?

Here's where I get properly interested, and it's not purely aesthetic.

Collagen loss isn't just a cosmetic issue. It's a marker of biological ageing. From our mid-thirties, we lose roughly 1% of our collagen per year. That rate accelerates significantly during the menopause transition, driven by the sharp decline in oestrogen.

The consequence? Skin that looks thinner, less resilient and more crepey, particularly around the jaw, temples and neck. But also: compromised skin barrier function, slower wound healing, and reduced structural integrity of connective tissue throughout the body.

Treating the skin, properly, is not vanity. It's part of the broader picture of maintaining tissue quality as we age, which is the same conversation I have with patients about inflammation, metabolic health and healthy ageing more generally.

Who Is JULÄINE For?

JULÄINE is particularly well suited to patients who are:

• Noticing a gradual loss of firmness or skin density, rather than deep, discrete lines

• In their forties or fifties, or beyond, and want a result that looks rested, not "done"

• Peri or post menopausal, when collagen loss accelerates

• Looking for a long-term investment in skin health, rather than a quick fix

• Concerned about the overfilled look, and want to restore their own structure rather than add to it

It's not a treatment for someone wanting immediate volume. The results build over 8 to 12 weeks as collagen synthesis ramps up, and they can last 18 to 24 months.

Patience is genuinely part of the protocol.

What to Expect

JULÄINE is administered as a series of injections, typically across two to three sessions spaced 4 to 6 weeks apart. Each session is individualised. The areas treated and the volumes used depend on your anatomy, your degree of collagen loss, and what you're trying to achieve.

It's not painful, but it's not nothing either. A topical anaesthetic is applied beforehand, and the product itself contains lidocaine, so discomfort is well managed.

Afterwards, there may be some swelling and mild bruising, which settles within a few days. You may also be asked to massage the treated areas to help ensure even distribution. I'll give you clear aftercare instructions before you leave.

How Does It Compare to Sculptra?

Sculptra is the original PLLA biostimulator and still a respected treatment. JULÄINE represents the next generation of the same underlying technology, with a more refined LASYNPRO formulation and updated delivery characteristics.

In practice, both stimulate collagen effectively. The differences are in the formulation detail and, potentially, the consistency of the tissue response. As with any injectable, the result depends as much on the technique and the practitioner's understanding of anatomy as it does on the product itself.

What matters most is not which product, but whether the approach is right for you.

My Clinical View

I'm not in the business of recommending treatments for the sake of it. My starting point is always the data: your skin quality, your hormonal status, your inflammation markers, your biology. Test, not guess.

For the right patient, JULÄINE is a genuinely impressive tool. It works with the body's own repair mechanisms rather than replacing them, and it does so through a mechanism, the M2 regenerative pathway, that lines up exactly with what I believe about ageing well: less inflammation, more repair. In a world full of treatments promising shortcuts, that's worth something.

If you'd like to discuss whether JULÄINE is appropriate for you, book a consultation at The Cosmetic Skin Clinic. We'll look at the full picture, not just the surface.

Dr Vix Manning is a GMC-registered aesthetic doctor and longevity specialist with over 30 years of clinical experience. She is Medical Director at The Cosmetic Skin Clinic (Bournemouth and Lymington).

Book a consultation →